small DEX droplets over the cells confi ned the microbubbles at the cell surface (Z-dimension). This method allowed us to place multiple, discrete or continuous treatment sites within the same monolayer (XY dimensions) without the use of specialized fl uidic devices, membrane plates or dish inversion. After patterning the DEX droplets, additional PEG was added to the dish without disturbing the patterning so that the active element at the tip of the ultrasound transducer (which was focused on the cells on the dish) was immersed. Application of ultrasound was then used to excite the microbubbles and generate cavitation, or rapid expansion and contraction of the microbubbles, resulting in bursting or shrinking of the microbubbles near the cells (Figure 1 D-F) , confi rming that the microbubbles in DEX behaved similarly as they do in cell culture medium. [ 25 ] It was possible to dispense droplets of DEX containing microbubbles in close proximity to one another for multiplexing and to generate a variety of specialized user-defi ned patterns (Figure 1 G) . Ultrasound excitation of the patterned microbubbles generated membrane disruption and induced cell death in discrete regions, as indicated by the staining pattern for annexinV (apoptosis) and propidium iodide (PI) (membrane disruption) in the microbubble patterned regions (Figure 1 H) .
We found that patterning was dependent on the type of microbubbles due to differential partitioning in the ATPS. We tested two types of commercially available microbubbles, Defi nitylipid coated microbubbles and Targestar-SA microbubbles (with and without antibody conjugation), to determine their partitioning in the PEG/DEX system ( Figure 2 A) . Defi nity microbubbles partitioned primarily to the PEG phase and to the interface for the phase systems we tested. This occurred because the non-polar lipid shells of the Defi nity microbubbles were more compatible with PEG. Targestar-SA microbubbles partitioned primarily to the interface and to the DEX phase. A greater proportion of microbubbles were observed in the DEX phase for lower DEX molecular weights (3500 and 10 000 kDa DEX), most likely because proteins such as streptavidin display stronger partitioning to DEX at low DEX molecular weights. This was true regardless of the presence of conjugated antibody. Partitioning to the interface was not only dependent on microbubble chemistry and size, but was also caused by buoyancy of the microbubbles in DEX.
Microbubble partitioning was confi rmed by placing microbubbles directly into DEX and then dispensing DEX/microbubble droplets into a solution of PEG (Figure 2 B) . Defi nity microbubbles rapidly moved to the interface, with some crossing the interface and entering the PEG. In contrast, Targestar-SA microbubbles remained well distributed in the DEX droplet. These experiments allowed us to monitor the distribution of microbubbles in DEX droplets and showed that Targestar-SA microbubbles remained in the DEX droplets in spite of their buoyancy.
We next tested the ability of various DEX/microbubble combinations to disrupt cell membranes upon ultrasound application in the presence of the cell impermeable dye PI (Figure 2 C). As expected, no PI staining was observed with ultrasound application to patterned DEX droplets using Defi nity microbubbles, as these microbubbles rapidly escaped from the DEX phase and fl oated to the surface of the PEG, where they had no effect on the cells. Patterned droplets containing Targestar-SA in cases where microbubbles are mixed in solution with suspended cells, the temporal variation of their spatial distribution in the bulk solution caused by buoyancy results in unpredictable outcomes, precluding detailed investigation of pore formation and cell injury/death.
In ultrasound molecular imaging, much effort has been devoted to developing strategies for decorating the exterior of encapsulated microbubbles with antibodies/ligands that target them to the surface of cells. [18] [19] [20] [21] Since these targeted microbubbles attach to cell membranes, they can also provide the opportunity to disrupt cell membranes. [22] [23] [24] For in vitro experiments, binding of targeted microbubbles to adherent cells is typically achieved by applying a small amount of solution containing the targeted microbubbles to the cells in a cell culture dish or to cells growing within a specialized chamber. In these examples, the microbubbles bind to the entire cell monolayer; therefore, sonoporation is induced in all cells with bound microbubbles. Such systems do not provide the spatial selection that is required to target subpopulations of cells within a monolayer. Furthermore, expensive antibodies/ligands are needed to attach the microbubbles to the cells.
In this study, we developed a novel approach to address these limitations by spatially patterning microbubbles using ATPSs and confi ning them to the surface of cells, where they can be subsequently excited by ultrasound. This approach allows localization of ultrasound-driven microbubbles to specifi c sites within a cell culture system, which cannot be achieved by any other currently available method. Furthermore, our system is compatible with most types of cell culture substrates including standard Petri dishes and well plates made from tissue culture plastics. The patterned microbubbles allow both the experimental treatments and the control (where cells within different regions are exposed to the same ultrasound condition without microbubbles nearby) to be simultaneously performed, in one step, in a single cell culture dish. By patterning microbubbles at multiple sites, multiple ultrasound conditions can be tested within the same culture dish, providing a multiplexed platform for effi cient investigation of ultrasound-mediated sonoporation and downstream effects on cells, including induction of apoptosis. Our approach provides an easy method for targeting cells because it does not require expensive antibodies or ligands for decorating the microbubbles.
Results

Microbubble Patterning
We achieved microbubble patterning by dispensing droplets of DEX containing microbubbles through a glass capillary needle onto a cell monolayer immersed in PEG. Prior to dispensing the microbubbles, we broke the end of the capillary to prevent clogging and shearing of bubbles during the dispensing process. The use of a capillary needle allowed us to dispense droplets of DEX ( ∼ 0.05-0.10 μ L) that were much smaller than droplets produced using a micropipettor (0.5-2.0 μ L) ( Figure 1 A-C) . DEX has a slightly greater density than PEG, causing the DEX droplets to sink and contact the cell monolayer. Spreading of the
Sonoporation of Sub-Populations of Cells within a Mono layer: Effects of Polymer Concentration, Microbubble Concentration and Cell Type
We applied our DEX/microbubble patterning system to investigate cell membrane disruption and death as a function of ultrasound pressure, polymer concentration, microbubble concentration and cell type. We used PI (applied after ultrasound) as a marker for cell membrane disruption and cell death. Since microbubbles could be arrayed with various spacing and number of treated regions, this allowed us to test multiple ultrasound conditions in parallel (e.g., different numbers of pulses and pressure amplitudes), essentially multiplexing the ultrasound treatment ( Figure 3 A) . Without ATPS localization (spatial scale of ∼ 0.75 mm 2 or less with ATPS), this type of multiplexing would not have been possible, since the ultrasound excitation covers a treatment area several times larger than the ATPS microbubble patterns.
We next tested different polymer concentrations of DEX in the 16% PEG 35 000 kDa/DEX 10 000 kDa system. Both the dextran and the PEG used in our system are biocompatible microbubbles, however, were able to disrupt cell membranes allowing entry of PI into cells in the DEX/microbubble-covered regions, even without antibody conjugation of the microbubbles to the cells. We did not notice a difference in the number of PI loaded cells following ultrasound treatment as a function of antibody concentration (i.e., with or without anti-CD31 antibody which targets HUVECs), indicating that the unattached microbubbles had an effect on cells by virtue of their close proximity to the cell surface, as dictated by the small height of the DEX droplet. This fi nding is important because it demonstrates the ability of micropatterned DEX droplets to spatially confi ne the microbubbles to the cell surface for sonoporation without the need for coupling to expensive antibodies.
For subsequent experiments we chose to use the DEX 10 000 kDa/PEG 35 000 kDa phase system with unconjugated Targestar-SA microbubbles, since this formulation displayed reasonable partitioning properties, and had polymer concentrations and viscosities low enough for use with cells. In addition, DEX 10 000 kDa showed more spreading on cells than DEX 500 000 kDa, ensuring that bubbles fl oating to the interface would still remain in close proximity to the cells. The ultrasound transducer is used to activate the bubbles which are contained within the DEX phase. D-F) High magnifi cation images of a single microbubble in DEX attached to a single cell (as indicated by the black arrows) before, during, and after ultrasound application captured with a high speed camera. This bubble was activated upon ultrasound treatment, undergoing rapid expansion and contraction, which resulted in bursting/shrinking on the cell, as visualized using ultrafast videomicroscopy. As microbubbles expand and contract during ultrasound application at 1.25 MHz, halos appear around the microbubbles due to rapid volume changes (E). After microbubble activation, the microbubbles disappear or become smaller in size (F). G) Microbubbles can be patterned with various user-defi ned array geometries, as indicated by patterning of a Michigan "M", visualized with intracellular PI staining after microbubble excitation. H) Apoptosis was selectively induced in the microbubble patterned regions treated with ultrasound (0.6 MPa, 8 μ s pulse) as indicated by annexinV (green) and PI (red) staining after ultrasound treatment. All images are for non-conjugated Targestar-SA microbubbles. Scale bars are ∼ 5 μ m in (D-F) and ∼ 300 μ m in (G) and (H).
www.afm-journal.de www.MaterialsViews.com wileyonlinelibrary.comand noncytotoxic; therefore, the polymers themselves had little to no direct effect on cell apoptosis. Moreover, the intracellular cytocompatibility of these polymers has been demonstrated using lipofection as a membrane disruption method, as well as through numerous studies that have used cell microinjection of fl uorophore-conjugated polymers such as dextran for cell tracing. For these experiments, a single ultrasound pulse was applied (8 μ s duration and 0.4 MPa peak negative pressure) to excite the microbubbles. A DEX concentration of 16% was optimal for maintaining an even distribution of microbubbles on the cells. Solutions of 8% DEX and 4% DEX produced clusters of microbubbles on the cells, resulting in uneven microbubble distribution, ineffi cient microbubble activation and reduced effi ciency of cell membrane disruption (Figure 3 B) . The clustering effect was likely due to equilibration of the DEX droplets in PEG, which caused the DEX solution to decrease dramatically in volume, resulting in microbubble aggregation.
Using the 16% PEG 35 000 kDa/16% DEX 10 000 kDa system, we tested the effect of microbubble concentration on membrane disruption. The highest concentration of microbubbles we tested was ∼ 0.5 × 10 9 /mL, which was determined by the maximum concentration of microbubbles provided by the manufacturer ( ∼ 1.0 × 10 9 /mL) and the maximum concentration of DEX 10 000 kDa that could be easily prepared (32%) mixed in equal parts (0.5X microbubble condition). We also tested microbubble concentrations that were 10-fold and 100-fold lower (0.05X and 0.005X microbubble conditions). The effi ciency of cell membrane disruption decreased dramatically as microbubble concentration decreased (Figure 3 C) .
It should be noted that the microbubble concentration we used ( ∼ 0.5 × 10 9 /mL) was much higher than what is typically used for sonoporation. The small volumes of our ATPS droplets made it possible for us to use such high concentration of microbubbles in our study. This would be prohibitive in a conventional sonoporation experiment due to the cost associated with the large amount of this reagent. Although it is expected that high bubble concentrations should generate the strongest sonoporation effects on cells, we have observed interactions among microbubbles (due to the secondary radiation force or Bjerknes force) at high microbubble concentrations. [ 26 , 27 ] This increased level of microbubble-microbubble interaction may infl uence their ability to produce direct effects on the cells during sonoporation. Thus, attempts to use microbubble concentrations much higher than those 
Platforms for Testing Cell Physiology: Apoptosis
Most platforms for wound healing research involve either physical damage/displacement or chemical ablation that completely removes the cells. [28] [29] [30] [31] In these assays, it is possible to quantify cell migration into cleared regions and secondary damage in the surrounding regions. However, many types of injuries in vivo do not result in complete removal of cells from the tissue all at once. Rather, cells undergo a more complex removal process where they die from direct trauma (necrosis) or initiate their own death in response to unfavorable environmental factors (apoptosis) and must then be cleared by immune cells in the surrounding tissue. Thus, a physiological model for tissue damage should involve both necrotic and apoptotic modes of cell death, where the damaged/dying cells remain in place throughout the process. As demonstrated by the results presented in Figure 3 E and Supporting Information Video 1, ultrasound excitation of patterned microbubbles can effectively generate cells death in targeted regions without removal of cells. Patterning microbubbles to control the location of this injury provides an ideal platform for investigating the physiology of the damaged cells and surrounding healthy regions.
used in this study are unlikely to further enhance the efficiency of sonoporation. Finally, we examined ultrasound-induced membrane disruption in different cell types using the 0.5X microbubble condition and the 16% PEG 35,000 kDa/16% DEX 10,000 kDa system. Of the fi ve cell types we tested, (HUVEC, NIH3T3, MDA 231, HeLa and HUVEC/NIH3T3/MDA231 co-cultures), HUVECs were most sensitive to membrane disruption, while the overall level of cell death was similar among all other cell types (Figure 3 D) . These results were expected because HUVECs, as with other types of primary cells, are typically more sensitive to physical or chemical disruption than immortalized cell lines and cancer cells. Cell death was less than 5% in control regions without microbubbles for all of the cell types we tested. Cell death was markedly reduced at 8% and 4% DEX concentrations. C) The proportion of dead cells decreased with decreasing microbubble concentrations. D) HUVECs were most sensitive to microbubble excitation, but cell death was similar among all the cell types we tested. Control regions without microbubbles showed minimal cell death (data compiled for all cell types). Bars in (B-D) denote mean ± SEM for n = 3 independent experiments. E) Time lapse imaging of microbubble targeted co-cultures of MDA231, NIH 3T3 and HUVECs showed that cell debris was gradually removed over the course of several days as the treated regions became repopulated by cells from surrounding untreated areas. Scale ∼ 60 μ m. Therefore, we next investigated the mechanism of sonoporation induced cell death. Using patterned microbubbles, we induced cell death in well-defi ned regions of the cell culture and stained with annexinV (to assay the appearance of phosphatidylserine on the cell surface) and PI (applied after ultrasound, to indicate loss of membrane integrity) (Figure 1 I, Figure 4 A). The annexinV-positive cells displayed a variety of morphologies indicative of apoptosis including changes in membrane appearance (roughening/ruffl ing), appearance of vacuoles and blebs and changes in nuclear morphology [ 32 , 33 ] (Figure 4 A) . We tested the effects of two ultrasound regimes on cell apoptosis in our system. The fi rst regime consisted of a low pressure ultrasound treatment over a long period (30 s) (Figure 4 B) . This treatment resulted in a low rate of acute apoptotic cell death, reaching a maximum of ∼ 20% at 0.1 MPa as determined by PI/annexinV labeling. The second regime consisted of a high pressure, short (8 μ s) pulse of ultrasound (Figure 4 C) . This treatment increased apoptotic cell death to ∼ 70% at 0.6 MPa.
In contrast to other forms of apoptosis, our treated cells were immediately positive for both the apoptosis marker annexinV and the secondary necrosis marker PI, with both markers generally localized to the same cells. This staining pattern may be due to the ability of microbubbles to simultaneously disrupt the plasma membrane and initiate apoptosis, as early apoptotic cells without membrane disruption would normally exclude PI. We hypothesized that apoptosis was initiated by an infl ux of extracellular calcium through ultrasound-induced membrane disruptions. We tested the effects of the levels of extracellular calcium on loss of cell viability/apoptosis in regions exposed to ultrasound treatment ( Figure 5 A-D) . Higher acoustic pressure (0.6 MPa) resulted in a higher percentage of cells labeled with PI and annexinV, as compared to lower acoustic pressure (0.3 MPa) (Figure 5 A,B) . This could be due to the fact that at higher acoustic pressures, more microbubbles were excited to initiate necrosis and apoptosis in more cells than at lower acoustic pressures. This is because smaller microbubbles usually require a higher acoustic pressure for cavitation to occur.
The extracellular calcium concentration had an important impact on both the percentage of PI positive cells and the percentage of annexinV positive cells. The percentage of dead cells (both PI-and annexinV-labeled) was markedly higher when the extracellular calcium concentration was increased to more than 5 mM, indicating the existence of a threshold for extracellular calcium above which there is an increase in the percentage of apoptotic cells. Interestingly, at lower calcium concentrations ( ≤ 2 mM) and at 0. what has been observed in other studies, [34] [35] [36] or more likely, that elevated extracellular calcium concentration increased the number of cells undergoing apoptosis. This was true for both high and low pressure ultrasound conditions. Finally, at high calcium concentrations ( ≥ 5.0 mM), low ultrasound pressures calcium concentrations (e.g., ≥ 5 mM), almost all of the cells that were PI-positive were also annexinV-positive, suggesting either that increased extracellular calcium helped to reduce the number of cells with acute necrotic death, possibly by facilitating membrane repair for some cells, in accordance with 
Patterning of Microbubbles with ATPS
Patterning techniques are frequently used in biomedical research for performing cell co-cultures, migration assays, wound healing assays, therapeutic targeting experiments and high throughput analyses. A variety of approaches have been developed for controlling placement of cells, including selective patterning of substrate materials, [ 38 , 39 ] and direct cell printing with inkjets, stencils and more recently ATPSs. [ 7 , 9 , 40-43 ] These technologies are useful for spatially organizing cells, but some cell types require patterning in situ (i.e., they are already growing on a surface). This is often the case for primary cells that have strict substrate requirements and a limited potential to divide in vitro. There are relatively few technologies that permit patterning on cells already growing as monolayers. ATPS micropatterning is capable of this type of patterning due to its biomolecule and particle partitioning ability. [ 6 , 8 ] Here, we demonstrated that ATPSs can be used to deliver microbubbles to preformed monolayers of cells.
Physical disruption of the plasma membrane can be achieved by microinjection, hydrodynamic delivery, magnetotransfection, laser poration, ballistic delivery and electroporation, in addition to sonoporation. [44] [45] [46] [47] Among these methods, electroporation and sonoporation are two of the most effective physical methods for disrupting membrane integrity. [48] [49] [50] [51] However, neither technique is traditionally amenable to patterning. We demonstrated that spatial patterning of sonoporation could be achieved using ATPSs to confi ne microbubbles, which are known to be highly effective sonoporation facilitators.
Our ATPS microbubble patterning strategy provides several advantages for sonoporation. First, it provides an easy way to precisely place microbubbles in close vicinity to cells, thereby providing a controlled sonoporation platform. In our system, the microbubbles reside directly above the cells and are well dispersed in the XY dimensions, as confi rmed by brightfi eld microscopy and our observations that microbubbles are in nearly the same focal plane as cells. This allowed us to overcome one of the main challenges in sonoporation research, the inherent unpredictability associated with free-fl oating microbubbles and controlling their impact on cells. Conventionally, sonoporation experiments have been conducted in centrifuge tubes or Petri dishes, where microbubbles are freely fl oating in the bulk solution. [52] [53] [54] [55] In these systems, the relative locations of the microbubbles and the cells are random and cannot be controlled. In some sonoporation experiments, cells are cultured inside thin chambers (e.g., Opticell). To ensure microbubbles are in contact with the cultured cells, these thin chambers are positioned upside down so that microbubbles fl oat up to the adherent cells. [56] [57] [58] However, this approach often leads to clustering of microbubbles at the boundaries of cells due to differences in the height of cells across the cell monolayer. In these systems, it is diffi cult, if not entirely impossible, to target a small region or sub-population of cells.
In our approach, the microbubbles can be easily positioned on any target cell population at controlled spatial locations. In We performed ratiometric calcium imaging using Fura-2AM to confi rm that calcium entered the cells as a result of microbubble excitation (Figure 5 E) . In the presence of extracellular calcium, there was a dramatic increase in the 340/380 nm ratio (corresponding to intracellular calcium concentration) that was observed immediately after the onset of ultrasound application, indicating that calcium was entering the cells driven by its concentration gradient. One consequence of rapid calcium infl ux is a loss of mitochondrial membrane potential, followed by further release of calcium from intracellular mitochondrial and endoplasmic reticulum stores, leading to propagation of intracellular pro-apoptotic signals. [ 37 ] We confi rmed that this occurred in the cells within the microbubble patterned regions by applying the JC1 ratiometric stain for mitochondrial membrane potential (Figure 5 F ). An increased level of green signal in the mitochondria indicated that mitochondrial function was disrupted by ultrasound induced calcium entry. Finally, to prove that cells entered the late stages of apoptosis, we assayed caspase activity using the Cell Event apoptosis detection kit ( Figure 5 G) . Several hours after ultrasound treatment, almost every cell displayed a staining pattern indicative of caspase activity (cleavage of the Cell Event dye which subsequently labeled the nucleus). These results suggest a model whereby ultrasound excitation of microbubbles in the presence of high extracellular calcium leads to cell death that is almost exclusively apoptotic in nature. Our data also suggests that apoptosis is most likely mediated by infl ux of calcium into the cells which triggers the apoptosis cascade. Cells are unable to survive as this cascade initiates, resulting in simultaneous loss of membrane integrity with onset of apoptosis.
Discussion
We developed a new method for patterning microbubbles for controlled ultrasound-mediated cell membrane disruption (i.e., sonoporation). Our approach is easy to perform, can be applied to cells growing on a variety of substrates and offers the ability to apply multiplexed ultrasound/microbubble treatments to a small number of cells. We tested two types of commercially available microbubbles and found that streptavidin-coated (Targestar-SA) microbubbles performed better within our system. Although both Defi nity and Targestar-SA microbubbles possess a perfl uorocarbon gas core bounded by a lipid shell, the difference in partitioning can be explained by the fact that the streptavidin on the surface of Targestar-SA microbubbles partitions to dextran. The ability to spatially pattern microbubbles enabled controlled and effective ultrasound treatment of cells. We demonstrated that patterning of microbubbles can be used to disrupt cell membranes of various cell types within defi ned regions, allowing intracellular entry of otherwise cell impermeant agents such as PI. The targeted areas could be monitored over several days to observe the cell responses in the damaged regions. We also demonstrated that the patterned microbubbles selectively induced apoptosis in subpopulations of cells following ultrasound treatment. This is relevant for researchers interested in apoptosis and useful studying apoptosis through transmembrane delivery of ionic or chemical initiators of apoptosis. Since our technique facilitates multiplexing of both microbubble condition and ultrasound treatment for testing the effects of sonoporation on cell viability, this may be useful for studying localized cell injury or apoptosis, while testing a wide range of treatments or acquiring a large number of independent observations. [ 62 , 63 ] Apoptotic cells are recognized and removed by resident macrophages in tissue; whereas damage caused by necrotic injury is not recognized by the immune system and can lead to toxicity in the surrounding tissue. [ 64 ] Since apoptosis is highly localized to specifi c cell populations in our system, ATPS microbubble patterning for ultrasound excitation may serve as a useful test system for investigating the interactions of apoptotic cells with surrounding cells, including the ability of healthy cells to migrate into apoptotic regions and remove debris. The effect that dying cells have on neighboring healthy populations can also be readily investigated in our system. Furthermore, by using ATPS and microbubbles to locally kill cells it will be possible to perform well controlled wound healing assays without physical removal of the damaged region. In our system, the wounded region consisting of both apoptotic and necrotic cells may represent a more physiologically relevant in vitro model for wound healing.
Future Directions
It will be useful to design easier to use setups to dispense the DEX droplets and apply ultrasound excitation to microbubbles. Development of new microbubbles that partition better in DEX can also help to improve and expand this technology. Finally, our technology may serve as a useful high throughput testing platform to investigate the mechanisms for various microbubble-potentiated ultrasound applications such as ultrasound mediated drug delivery for cancer treatment, [ 65 ] as well as ultrasound tissue ablation, where fractionation, necrosis and enhanced apoptosis have been identifi ed as factors benefi cial for treatment. [66] [67] [68] 
Experimental Section
ATPS Formulation : ATPSs were formulated from DEX (ranging in molecular weight from 3500 kDa to 500 000 kDa; Pharmacosmos, Denmark) and PEG 35 000 kDa (Sigma, St. Louis, MO). These polymers were reconstituted as aqueous solutions in various buffered media. The initial formulations tested were near critical point concentrations of 9% DEX 3500 kDa/10% PEG 35 000 kDa, 7% DEX 10 000 kDa/7% PEG 35 000 kDa, and 3.2% DEX 500 000 kDa/2.5% PEG 35 000 kDa in their fully equilibrated forms. For experiments that required additional reagents in the ATPS solutions, concentrations slightly higher than the critical points were used (e.g., stock solutions of 16% DEX 10 000 kDa/16% PEG 35 000 kDa, corresponding to a solution of approximately 8% DEX 10 000 kDa/8% PEG 35 000 kDa after full equilibration. ATPSs formed from stock solutions of 8% DEX 10 000 kDa/16% PEG 35 000 kDa and 4% DEX 10 000 kDa/16% PEG 35 000 kDa were also tested.
Microbubble Partitioning : Two types of commercially available ultrasound contrast agent microbubbles were used in this study: Defi nity (Lantheus Medical Imaging, Billerca, MA) and Targestar-SA (Targeson, San Diego, CA). Defi nity microbubbles are composed of most types of ultrasound experiments, long sonoporation treatment durations are used to maximize the chance of free-fl oating microbubbles impacting the cells. Since our approach minimizes free-fl oating microbubbles, we used short (microsecond) ultrasound durations; therefore, the microbubble dynamics are better controlled without large translational movements due to effects such as microstreaming.
Our system can be used for cells that grow on virtually any substrate, making this approach more versatile and adaptable. The ATPS medium itself imposes no acoustic discontinuity above the cells while confi ning the bubbles within a fl uid (this is problematic for most microdevices). In addition, our approach reduces the amount of reagent and the number of microbubbles by as much as 10 000-fold because microbubbles are confi ned in 0.1 μ L DEX droplets instead of 10 mL solutions used in conventional sonoporation experiments in a dish or similar container. Since we use small amounts of microbubbles and can generate well defi ned patterns, this approach is highly amenable to multiplexing ultrasound parameters, the microbubble type/ concentration, and the concentration and type of biomolecule present in the extracellular space. The fi nal advantage of our system relates to the need for antibody/microbubble conjugation. For targeted microbubble applications, antibody conjugation is needed to ensure microbubble targeting and attachment to the cell surface. Our approach does not require antibodies for targeting cells because the DEX droplets confi ne the microbubbles at the cell surface. This allows the same microbubbles to be used with any cell type without any modifi cation.
Implications for Apoptosis Research
Ultrasound-excited microbubbles that are capable of generating signifi cant physical impact on cells at the micro-and nano-scales provide a unique tool for manipulation of cells. Patterning of microbubbles using ATPSs provides a novel system with great potential for new applications. In this study, we demonstrated a novel application of ATPS microbubble patterning for selectively inducing apoptosis. A number of studies have shown sonoporation induced apoptosis in cells, [ 52 , 59-61 ] although the mechanisms are not completely understood. Moreover, in sonoporation-mediated gene delivery experiments, a large number of cells are often damaged or killed by ultrasound-activated microbubbles, although the number of dead cells and the mechanism of their death (i.e., apoptosis vs necrosis) are not always clearly reported in the literature. In our study, the spatial localization and patterning of microbubbles using ATPS enabled detailed investigation of ultrasound excitation of microbubbles and their effects on the cells. With ATPS microbubble patterning, we induced a high proportion of cells to enter apoptosis in targeted areas within a monolayer by inducing calcium infl ux into the cells during sonoporation. Based on our previous experiments using DEX as a delivery vehicle for lipofection agents, the DEX and PEG polymers have little to no effect on cell viability. Therefore, apoptosis was mediated by microbubble-induced membrane damage and calcium infl ux, as evidenced by a dose response to extracellular calcium. This example illustrates that our technology of ATPS microbubble patterning may be used as a potential platform for (Photron FASTCAM SA1, San Diego, CA) at a frame rate of 20 000 frames s − 1 . A cooled CCD camera (Photometrics QuantEM, Tucson, AZ, USA), a monochromator with 5 nm bandpass (DeltaRAM X, PTI, Birmingham, NJ, USA) and a polychroic fi lter (73000v2, Chroma, Rockingham, VT, USA) were used to perform ratiometric epifl uorescence and standard epifl uorescence imaging of molecules delivered by sonoporation. The ultrasound treatments were applied either as single 8 μ sec pulses or as continuous (30 s) wave forms that varied in peak acoustic pressure from 0.05 MPa to 0.6 MPa.
Apoptosis and Calcium Infl ux : To investigate whether calcium infl ux during sonoporation plays a role in sonoporation triggered apoptosis in our system, we used PEG solutions containing various calcium concentrations either in a buffer designed to mimic the intracellular ion concentration of cells (Cytomix) [ 69 ] or in PBS/DPBS. Calcium concentrations ranged from 0 to 20 mM. Cells were exposed to either 0.3 or 0.6 MPa peak acoustic pressures and allowed to recover for 15 min at room temperature before washing in PBS. Cells were then washed in annexinV binding buffer and incubated with a solution containing Alexa 488-annexinV (Invitrogen) and PI to detect apoptosis. Regions with microbubbles were compared to regions without microbubbles and the total number of PI-positive and annexinV-positive cells was quantifi ed as before for each condition, with the exception that PI was added after ultrasound treatment and used as a dead cell marker. Ratiometric imaging using Fura-2 AM (Invitrogen) was used to confi rm that changes in intracellular calcium had occurred following ultrasound treatment. For ratiometric calcium imaging, cells were loaded with Fura2-AM before ultrasound by incubating the cells with Fura2-AM and Pluronic F-127 (0.05% v/v of 10% w/v) for 60 min at 37 ° C. The cells were then washed 3 times to remove extracellular Fura-2AM. [ 70 ] To quantify intracellular calcium concentration following ultrasound, the ratio of signal at 340/380 nm was calculated for each treated cell.
Viability Assays : To analyze cell viability as a function of ultrasound/ calcium-induced apoptosis, we used several independent tests. PI staining, applied after ultrasound treatment, revealed cells that were not able to reseal their membranes after sonoporation, while annexinV labeling was used as an early stage marker for apoptosis. Phase contrast images were used to quantify the total number of cells in each image and the percentage of annexinV-and PI-positive cells was calculated for various ultrasound and calcium conditions. Phase contrast and PI images also allowed us to qualitatively inspect the status of cells in terms of general morphology, membrane features and nuclear morphology. JC1 ratiometric staining (Invitrogen) was used to confi rm that mitochondrial membrane potential was disrupted in the apoptotic cells. Cell Event caspase stain (Invitrogen) was used to confi rm that cells entered the late stages of apoptosis.
Data Analysis : Image J and MetaFluor Analyst (Molecular Devices, Downingtown, PA, USA) photometric software were used for image analysis. Mosaic and live cell images were captured, compiled and stitched using Zeiss Axiovision software. Statistical analyses were carried out using Sigmaplot with Sigmastat. All graphs are presented as mean values ± standard error of the mean.
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author. a C 3 F 8 gas core, encapsulated by a phospholipid shell. Targestar-SA is a perfl uorocarbon microsphere, encapsulated with a lipid shell coated with streptavidin, which permits biotinylated ligands to bind to its surface via biotin-streptavidin conjugation chemistry. The affi nities of different microbubbles for the above phase systems were tested by mixing stock solutions of microbubbles in equal concentrations of twice-concentrated solutions of PEG and DEX in a microcentrifuge tube. The phase systems were then allowed to separate by gravity at room temperature. Once the phase systems reached equilibrium ( ∼ 10 min), samples were taken from the top (PEG) and bottom (DEX) phases along with the PEG/DEX interface and diluted below the critical point (1:10 in PBS) to remove any residual PEG/DEX droplets that could be mistaken for microbubbles. Microbubbles were placed on a hemocytometer and imaged under brightfi eld illumination using a 10x objective. Images were imported into imageJ and numbers of microbubbles were automatically quantifi ed using the automated nuclei counting plugin (Center for BioImage Informatics, UCSB). Partitioning was measured for Defi nity lipid coated microbubbles, Targestar-SA microbubbles (without antibody) and Targestar-SA microbubbles conjugated to biotinylated IgG by counting the numbers of microbubbles in each phase. Partitioning was also investigated by placing the microbubbles within non-equilibrated twiceconcentrated solutions of DEX which were then deposited into PEG as 1 μ L droplets. The movement of microbubbles within the DEX droplets was monitored using video microscopy.
Cell Culture : Human umbilical vein endothelial cell (HUVEC) preparations (passage number 3-7) were plated one day prior to the experiment onto tissue culture treated 35 mm 2 glass bottom dishes. NIH3T3, MDA231 and HeLa cells were cultured under standard conditions and then either seeded separately or as mixtures (co-cultures) in HUVEC medium in 35 mm 2 glass bottom dishes one day prior to the experiment. A seeding density of 200 cells/mm 2 was used to ensure ∼ 80% confl uence the following day. Cultures were maintained in a humidifi ed incubator at 37 ° C, with 5% CO 2 . For experimental treatments, cultures were removed from the incubator, covered with a solution of 16% PEG, patterned with DEX/microbubbles and immediately treated by ultrasound. After 10 min incubation, the ATPS was removed through 3-5 consecutive washes in PBS. The cells were then either reintroduced to culture medium and returned to standard incubation conditions for later analysis or immediately stained and imaged.
Microbubble Preparation and ATPS Micropatterning : Microbubbles ( ∼ 1 × 10 9 particles per mL) were incorporated into the DEX phase by mixing a solution of 32% DEX 10 000 kDa with an equal volume of microbubbles to obtain a solution of ∼ 0.5 × 10 9 microbubbles/mL in 16% DEX, representing the optimal microbubble concentration. Solutions with 10-fold and 100-fold lower microbubble concentrations were also tested. The microbubble solutions were loaded into capillary needles that were positioned above the PEG coated cells. Capillary tips were lowered into the PEG and droplets of DEX containing microbubbles ( ∼ 0.05-0.1 μ L in volume) were dispensed in the desired patterns above the cells. These droplets sank vertically in the PEG solution, where they came into contact with the cells and spread on the cell monolayer. Once the fi nal droplet was in place, the micropatterned cultures were ready for ultrasound exposure.
Experimental Setup for Ultrasound Application : The experimental setup consisted of a microscope equipped with a non-focused circular ultrasound transducer (center frequency 1.25 MHz, active element diameter 0.6 cm) (Advanced Devices, Wakefi eld, MA, USA) that was driven by a function generator (33250A, Agilent Technologies, Palo Alto, CA, USA) and an amplifi er (75A250, Amplifi er Research, Souderton, PA, USA). The transducer was calibrated in free fi eld in water using a calibrated 40 μ m needle hydrophone (HPM04/1, Precision Acoustics, Dorchester, UK). The transducer was positioned at 45 degrees (to avoid standing wave buildup and accommodate simultaneous microscopic imaging) with its active surface ∼ 7.5 mm (Rayleigh distance) from the cell culture surface such that the maximum ultrasonic pressure was focused on the cells. This confi guration allowed us to simultaneously apply ultrasound and microscopically observe microbubbles. Ultrasound excitation of microbubbles was monitored by a high speed camera
